Eli Lilly and Company Stock

Lilly Endowment sells $31.18 million in Eli Lilly stock

INDIANAPOLIS—Lilly Endowment Inc., a major shareholder in Eli Lilly & Co. (NYSE:LLY), has recently sold a significant portion of its holdings in the pharmaceutical giant. According to a recent SEC filing,

MarketWatch · 2h

Eli Lilly & Co. stock underperforms Friday when compared to competitors

Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow Jones Industrial Average DJIA falling 0.37% to 44,546.08.

The Motley Fool · 1d

GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative. The stock is reasonably valued given the growth opportunities in front of it.

Hosted on MSN · 1d

Is Eli Lilly and Company (LLY) the Best Large Cap Dividend Growth Stock to Buy Now?

We recently compiled a list of the 14 Best Large Cap Dividend Growth Stocks To Buy Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other large cap dividend growth stocks.

Eli Lilly (LLY) Stock Eyes Price Breakout as Q4 Results Loom

Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

Nasdaq1mon

Has Eli Lilly Stock Peaked?

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world ... like it might be on track to be the first healthcare company to top a $1 trillion valuation, perhaps as early as ...

3don MSN

Eli Lilly and Company (LLY): A Bull Case Theory

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...

The Motley Fool on MSN8d

Why Eli Lilly Stock Popped on Thursday

Eli Lilly ( LLY 0.69%) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in ...

Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

6LLY : Behind the Scenes of Eli Lilly's Latest Options Trends

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

3don MSN

Jim Cramer Backs Eli Lilly (LLY): Will Its Drug Pipeline Dominate Pharma?

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results